MMedication Read More Stitch Fix, apparel retailers may benefitApril 9, 2026 Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a…
EEconomy Read More UK faces rising bills as new tax year startsApril 8, 2026 The headquarters of HM Revenue and Customs near the Houses of Parliament in the Westminster district of London,…
EEconomy Read More 5 things to know before the market opens TuesdayApril 7, 2026 This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning, and congratulations to…
EEconomy Read More Trump tariffs fall, but trade war impacts lingerApril 3, 2026 A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off…
HHealth Read More Novo Nordisk stock rises after Wegovy recommended by UK’s drug price watchdogApril 1, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4%…
EEconomy Read More China Development Forum welcomes U.S. execs revamping market pushMarch 24, 2026 Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the…
MMedication Read More Restaurants add protein, fiber for weight loss drug usersMarch 21, 2026 A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to…
HHealthcare Read More Eli Lilly launches program to boost employer coverage of obesity drugsMarch 5, 2026 Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
HHealthcare Read More Why Novo Nordisk’s Ireland expansion is key to fighting off Eli LillyMarch 2, 2026 Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
HHealthcare Read More Eli Lilly’s lead in the obesity race gets wider after win against NovoFebruary 25, 2026 In the lucrative obesity drug race, there is Eli Lilly — and then there’s everybody else. A pair…
HHealthcare Read More These 4 charts show the scale of Novo Nordisk’s woesFebruary 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
EEconomy Read More Unstable tariff situation and new AI disruption spark market sell-offFebruary 24, 2026 Futures-options traders work on the floor at the New York Stock Exchange’s NYSE American (AMEX) in New York…